Literature DB >> 6852387

Proliferative vasculopathy and an hydranencephalic-hydrocephalic syndrome: a neuropathological study of two siblings.

C Harper, A Hockey.   

Abstract

Two female siblings were born with an hydranencephalic-hydrocephalic syndrome, following pregnancies complicated by hydramnios. No environmental factors such as infections, drugs or metabolic disorders were noted during either pregnancy. Neuropathological studies revealed identical changes in each case. The characteristic feature of the pathology was a proliferative vasculopathy throughout the central nervous system, which apparently caused focal ischaemic lesions and progressive destruction of CNS tissue. The defect probably is inherited as an autosomal recessive trait.

Entities:  

Mesh:

Year:  1983        PMID: 6852387     DOI: 10.1111/j.1469-8749.1983.tb13747.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  3 in total

1.  Lack of Flvcr2 impairs brain angiogenesis without affecting the blood-brain barrier.

Authors:  Nicolas Santander; Carlos O Lizama; Eman Meky; Gabriel L McKinsey; Bongnam Jung; Dean Sheppard; Christer Betsholtz; Thomas D Arnold
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome).

Authors:  Esther Meyer; Christopher Ricketts; Neil V Morgan; Mark R Morris; Shanaz Pasha; Louise J Tee; Fatimah Rahman; Anne Bazin; Bettina Bessières; Pierre Déchelotte; Mohamed T Yacoubi; Mudher Al-Adnani; Tamas Marton; David Tannahill; Richard C Trembath; Catherine Fallet-Bianco; Phillip Cox; Denise Williams; Eamonn R Maher
Journal:  Am J Hum Genet       Date:  2010-03-04       Impact factor: 11.025

3.  Aprosencephaly: review of the literature and report of a case with cerebellar hypoplasia, pigmented epithelial cyst and Rathke's cleft cyst.

Authors:  T S Kim; S Cho; D W Dickson
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.